MAPK pathway mediates muscarinic receptor-induced human lung fibroblast proliferation

Life Sciences

Volumn 80, Issue 24-25, 2007, Pages 2259-2262

  Matthiesen, Sonja ^a   Bahulayan, Amit ^a   Holz, Olaf ^b   Racké, Kurt ^a  

^a UNIVERSITY OF BONN   (Germany)

^b KRANKENHAUS GROSSHANSDORF   (Germany)

Author keywords

ERK; Lung fibroblasts; MAPK; Muscarinic receptor; Proliferation; Remodelling; Tiotropium

Indexed keywords

2 (2 AMINO 3 METHOXYPHENYL)CHROMONE; ATROPINE; CARBACHOL; CHOLINERGIC RECEPTOR BLOCKING AGENT; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 1; MITOGEN ACTIVATED PROTEIN KINASE 3; MUSCARINIC RECEPTOR; OXOTREMORINE; THYMIDINE; TIOTROPIUM BROMIDE;

ARTICLE; ASTHMA; CELL PROLIFERATION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; LUNG FIBROBLAST; PROTEIN EXPRESSION; RECEPTOR UPREGULATION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

BLOTTING, WESTERN; CARBACHOL; CELL LINE; CELL PROLIFERATION; CHOLINERGIC AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; FIBROBLASTS; FLAVONOIDS; HUMANS; LUNG; MAP KINASE SIGNALING SYSTEM; MITOGEN-ACTIVATED PROTEIN KINASE 1; MITOGEN-ACTIVATED PROTEIN KINASE 3; RECEPTORS, MUSCARINIC; SIGNAL TRANSDUCTION; THYMIDINE; TRITIUM;

EID: 34249284422     PISSN: 00243205     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.lfs.2007.02.027     Document Type: Article

References (18)

1. Anzueto A., Tashkin D., Menjoge S., and Kesten S. One-year analysis of longitudinal changes in spirometry in patients with COPD receiving tiotropium. Pulmonary Pharmacology and Therapeutics 18 (2005) 75-81
2. Caulfield M.P., and Birdsall N.J.M. International Union of Pharmacology. XVII. Classification of muscarinic acetylcholine receptors. Pharmacological Reviews 50 (1998) 279-290
3. Dudley D.T., Pang L., Decker S.J., Bridges A.J., and Saltiel A.R. A synthetic inhibitor of the mitogen-activated protein kinase cascade. Proceedings of the National Academy of Sciences of the United States of America 92 (1995) 7686-7689
4. Dumaz N., and Marais R. Integrating signals between cAMP and the RAS/RAF/MEK/ERK signalling pathways. FEBS Journal 272 (2005) 3491-3504
5. Gosens R., Nelemans S.A., Grootte Bromhaar M.M., McKay S., Zaagsma J., and Meurs H. Muscarinic M3-receptors mediate cholinergic synergism of mitogenesis in airway smooth muscle. Journal of Respiratory Cell and Molecular Biology 28 (2003) 257-262
6. Gosens R., Bos I.S., Zaagsma J., and Meurs H. Protective effects of tiotropium bromide in the progression of airway smooth muscle remodeling. American Journal of Respiratory and Critical Care Medicine 171 (2005) 1096-1102
7. Gu J., and Iyer V.R. PI3K signaling and mRNA expression during the response of quiescent human fibroblasts to distinct proliferative stimuli. Genome Biology 7 (2006) R42
8. Jacobs J.P., Jones C.M., and Baille J.P. Characteristics of a human diploid cell designated MRC-5. Nature 227 (1970) 168-170
9. Jeffery P.K. Remodeling in asthma and chronic obstructive lung disease. American Journal of Respiratory and Critical Care Medicine 164 (2001) 28S-38S
10. Krymskaya V.P., Orsini M.J., Eszterhas A.J., Brodbeck K.C., Benovic J.L., Panettieri R.A., and Penn R.B. Mechanisms of proliferation synergy by receptor tyrosine kinase and G protein-coupled receptor activation in human airway smooth muscle. Journal of Respiratory Cell and Molecular Biology 23 (2000) 546-554
11. Luttrell L.M. Activation and targeting of mitogen-activated protein kinases by G-protein-coupled receptors. Candian Journal of Physiology and Pharmacology 80 5 (2002) 375-382
12. Marinissen M.J., and Gutkind J.S. G-protein-coupled receptors and signaling networks: emerging paradigms. Trends in Pharmacological Sciences 22 (2001) 368-376
13. Matthiesen S., Bahulayan A., Kempkens S., Fuhrmann R., Stichnote C., Haag S., Juergens U.R., and Racké K. Muscarinic receptors mediate stimulation of human lung fibroblast. American Journal of Respiratory Cell and Molecular Biology 35 6 (2006) 621-627
14. Racké K., and Matthiesen S. The airway cholinergic system: physiology and pharmacology. Pulmonary Pharmacology and Therapeutics 17 (2004) 181-198
15. Racké K., Juergens U.R., and Matthiesen S. Control by cholinergic mechanisms. European Journal of Pharmacology (special issue on The Pharmacology of the Respiratory Tract) 533 (2006) 57-68
16. Roux P.P., and Blenis J. ERK and p38 MAPK-activated protein kinases: a family of protein kinases with diverse biological functions. Microbiology and Molecular Biology Reviews 68 (2004) 320-344
17. Vincken W., van Noord J.A., Greefhorst A.P., Bantje T.A., Kesten S., Korducki L., and Cornelissen P.J. Improved health outcomes in patients with COPD during 1 yr's treatment with tiotropium. European Respiratory Journal 19 (2002) 209-216
18. Zaagsma J., Bos I.S., Gosens R., and Meurs H. Comparative study of the effects of tiotropium bromide and budesonide on allergen-induced airway remodeling. European Respiratory Journal 28 Suppl. 50 (2006) 2532